A

Aier Eye Hospital Group Co Ltd
SZSE:300015

Watchlist Manager
Aier Eye Hospital Group Co Ltd
SZSE:300015
Watchlist
Price: 14.28 CNY -4.86% Market Closed
Market Cap: 132B CNY
Have any thoughts about
Aier Eye Hospital Group Co Ltd?
Write Note

Aier Eye Hospital Group Co Ltd
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aier Eye Hospital Group Co Ltd
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
Accrued Liabilities
ÂĄ828.4m
CAGR 3-Years
15%
CAGR 5-Years
20%
CAGR 10-Years
26%
H
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
Accrued Liabilities
ÂĄ217.3m
CAGR 3-Years
45%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Hengkang Medical Group Co Ltd
SZSE:002219
Accrued Liabilities
ÂĄ122.4m
CAGR 3-Years
11%
CAGR 5-Years
-8%
CAGR 10-Years
35%
X
XiAn International Medical Investment Co Ltd
SZSE:000516
Accrued Liabilities
ÂĄ194.4m
CAGR 3-Years
29%
CAGR 5-Years
38%
CAGR 10-Years
16%
H
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Accrued Liabilities
ÂĄ265.8m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sanbo Hospital Management Group Ltd
SZSE:301293
Accrued Liabilities
ÂĄ113.6m
CAGR 3-Years
-3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Aier Eye Hospital Group Co Ltd
Glance View

Market Cap
133.2B CNY
Industry
Health Care

Aier Eye Hospital Group Co., Ltd., founded in 2001 and headquartered in Changsha, China, has emerged as a leading player in the ophthalmology healthcare sector in Asia. Starting as a single eye clinic, it has grown exponentially to encompass a vast network of over 60 hospitals and numerous outpatient service centers across China and beyond. The company focuses on providing comprehensive eye care services, including cataract surgery, myopia treatment, and other advanced healthcare solutions, leveraging cutting-edge technology and innovative techniques. With a dedicated team of skilled specialists and a commitment to enhancing patient outcomes, Aier aims to address the increasing demand for vision care in a rapidly aging population, underpinned by a robust business model that merges quality healthcare delivery with strategic expansion. As an investor, Aier Eye Hospital presents a compelling opportunity in the burgeoning health sector. With healthcare spending expected to rise in China and globally, Aier's prominence in eye care positions it well to tap into this growing market. The company's commitment to research and development ensures continuous innovation and adaptation to emerging healthcare trends, setting it apart from traditional healthcare providers. Furthermore, Aier's expansion strategy, including potential international outreach, offers a promise of sustained growth. By investing in Aier, one is not just supporting a service provider but joining a forward-thinking healthcare institution that is poised to redefine eye care and generate significant returns.

Intrinsic Value
18.1 CNY
Undervaluation 21%
Intrinsic Value
Price
A

See Also

What is Aier Eye Hospital Group Co Ltd's Accrued Liabilities?
Accrued Liabilities
828.4m CNY

Based on the financial report for Sep 30, 2024, Aier Eye Hospital Group Co Ltd's Accrued Liabilities amounts to 828.4m CNY.

What is Aier Eye Hospital Group Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
26%

Over the last year, the Accrued Liabilities growth was 12%. The average annual Accrued Liabilities growth rates for Aier Eye Hospital Group Co Ltd have been 15% over the past three years , 20% over the past five years , and 26% over the past ten years .

Back to Top